Links

Public Private Partnerships (PPPs)

  • Global Forum for Health Research
    Focuses research efforts on diseases representing the heaviest burden on the world's health and facilitating collaboration between partners in both the public and private sectors.
  • Initiative on Public-Private Partnerships for Health (IPPPH)
    Aims at increasing the effectiveness of public-private collaboration, particularly by helping those seeking to develop health products, or to improve access to such products needed to fight neglected diseases and other health problems in developing countries.
  • Aeras Global TB Vaccine Foundation
    Aeras is a non-profit organization working through public-private partnerships to develop new tuberculosis vaccines and to ensure that they are distributed to all who need them around the world.
  • Drugs for Neglected Diseases Initiative (DNDi)
    DNDi is a not-for-profit initiative that aims to research and develop drugs for people debilitated by neglected diseases, by using existing R&D capacity in both rich and poor countries.
  • Global Alliance for TB Drug Development
    The Global Alliance for TB Drug Development is a public-private partnership driven to halt the rise and reverse the spread of TB by developing new, faster-acting and affordable tuberculosis medicines.
  • Medicines for Malaria Venture (MMV)
    MMV is a nonprofit foundation created to discover, develop and deliver new affordable antimalarial drugs through effective public-private partnerships.
  • International Partnership for Microbicides (IPM)
    IPM has been established to accelerate the discovery, development and accessibility of microbicides to prevent transmission of HIV.
  • International AIDS Vaccine Initiative (IAVI)
    IAVI is a global not-for-profit organization working to speed the search for a vaccine to prevent HIV/AIDS, focusing on developing countries.
  • Malaria Vaccine Initiative (MVI)
    MVI is a focused vaccine development program created to accelerate the development of malaria vaccines and ensure their availability and accessibility in the developing world.
  • Tuberculosis Diagnostics Initiative (TBDI)
    TBDI develops new diagnostic tests that are appropriate for use in low-income countries. The initiative partners with industry, academic researchers, and national and local health officials to facilitate and accelerate the development of priority diagnostic tools.
  • Sexually Transmitted Diseases Diagnostics Initiative (SDI)
    SDI aims to promote the development, evaluation and application of diagnostic tests for sexually transmitted infections (STI) appropriate for use in primary health care settings in developing countries.